Generation of functionally mature dendritic cells from elutriated monocytes using polyinosinic : polycytidylic acid and soluble CD40 ligand for clinical application.
Despite the increasing use of dendritic cell (DC) vaccination in clinical trials, optimal conditions for the generation of functionally mature DCs remain to be established. The current standard DC maturation protocol for clinical trials has been used as an inflammatory cytokine cocktail [tumour necrosis factor (TNF)-alpha, interleukin (IL)-1beta, IL-6 and prostaglandin E(2)], but this cocktail induced insufficient maturation of DCs derived from elutriated monocytes when cultured in X-VIVO 15. The aim of this study was to define effective combinations of stimulators for generating functionally mature DCs from elutriated monocytes under current good manufacturing practice conditions. We compared the functional capacity of DCs in response to all possible pairwise combinations of four different classes of stimuli: TNF-alpha, peptidoglycan, polyinosinic : polycytidylic acid [poly(I:C)] and soluble CD40 ligand (CD40L). Maturation status of DCs stimulated with combination of four stimuli was similar to that of the cytokine cocktail as assessed by the cell surface phenotype. However, only the combination of poly(I:C) + CD40L induced complete functional activation of the whole DC population, assessing IL-12p70 production, allostimulatory activity, migratory response to CCL19 and T helper 1-polarizing capacity. Thus, the protocol based on the combination of poly(I:C) and CD40L is more effective for the induction of clinical-grade DCs from elutriated monocytes than the standard cytokine cocktail.
Kim
S
S
Department of Laboratory Medicine, Yonsei University College of Medicine, 134 Shinchon-Dong, Seodaemoon-Gu, Seoul 120-752, Korea.
Kim
H O
HO
Kim
H J
HJ
Lee
K
K
Kim
H-S
HS
D023201:CD40 Ligand / Q000276:immunology*; D002454:Cell Differentiation / Q000276:immunology; D016764:Cell Polarity / Q000276:immunology; D002634:Chemotaxis, Leukocyte / Q000276:immunology; D016207:Cytokines / Q000096:biosynthesis; D003713:Dendritic Cells / Q000276:immunology*; D006801:Humans; D016130:Immunophenotyping; D007369:Interferon Inducers / Q000276:immunology; D007937:Leukapheresis / Q000379:methods; D007959:Lymphocyte Culture Test, Mixed; D009000:Monocytes / Q000276:immunology; D011070:Poly I-C / Q000276:immunology*; D018417:Th1 Cells / Q000276:immunology; D018418:Th2 Cells / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology
D016207:Cytokines; D007369:Interferon Inducers; D014409:Tumor Necrosis Factor-alpha; D023201:CD40 Ligand; D011070:Poly I-C
Nature. 1998 Mar 19;392(6673):245-52
9521319
Vaccine. 2002 Dec 19;20 Suppl 4:A8-A22
12477423
Cytotherapy. 2004;6(4):363-71
16146889
Annu Rev Immunol. 2000;18:593-620
10837070
Blood. 2006 Jul 15;108(2):544-50
16537810
Cancer Immunol Immunother. 2004 Mar;53(3):240-8
14685779
J Immunol. 1995 Apr 15;154(8):3821-35
7706722
Transfusion. 2007 Dec;47(12):2290-6
17764512
J Immunol. 2006 May 1;176(9):5153-9
16621978
Adv Immunol. 1998;70:83-243
9755338
J Immunother. 2007 Jul-Aug;30(5):567-76
17589298
Immunobiology. 2006;211(6-8):633-40
16920502
Infect Immun. 2005 Dec;73(12):7967-76
16299289
J Immunol. 2006 Dec 15;177(12):8676-83
17142768
Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9305-10
10430938
J Exp Med. 1996 Oct 1;184(4):1413-24
8879213
J Exp Med. 2000 May 1;191(9):1581-90
10790432
Int Immunol. 2000 Jun;12(6):807-15
10837408
Nat Rev Immunol. 2008 May;8(5):362-71
18379575
Blood. 2004 Oct 15;104(8):2235-46
15231572
Int Immunol. 1998 Nov;10(11):1593-8
9846688
Nat Immunol. 2005 Aug;6(8):769-76
15995707
J Immunother. 2005 Sep-Oct;28(5):480-7
16113604
J Immunol. 2000 Oct 1;165(7):3584-91
11034359
Blood. 2000 Nov 15;96(10):3499-504
11071647
J Leukoc Biol. 2004 Jan;75(1):106-16
14525963
Annu Rev Immunol. 2000;18:245-73
10837059
Blood. 2001 Jun 1;97(11):3466-9
11369638
J Exp Med. 1999 Mar 1;189(5):821-9
10049946
J Immunol. 1999 Jul 1;163(1):57-61
10384099
Infect Immun. 2005 Aug;73(8):5212-6
16041042
Yonsei Med J. 2004 Jun 30;45 Suppl:48-52
15250050
Transfusion. 2003 Sep;43(9):1309-16
12919435
Nat Immunol. 2004 Aug;5(8):800-8
15220916
Nature. 2006 May 4;441(7089):101-5
16625202
Trends Immunol. 2007 May;28(5):227-33
17403614
Immunol Lett. 2008 Jan 15;115(1):1-8
18001846
Blood. 2006 Feb 15;107(4):1528-36
16239433
Science. 1999 Feb 19;283(5405):1183-6
10024247
Int Rev Immunol. 2006 Sep-Dec;25(5-6):377-413
17169781
J Immunol Methods. 2005 Mar;298(1-2):61-72
15847797